Scrip News - Fasting glucose and postprandial glycemia: which is the best target for improving outcomes? The Apollo and 4-T Trials

Scrip Clinica RAJ Scrip Clinical Research AnimalPharm

Advanced Search

Research & Development

Supplements & Reports

Fasting glucose and postprandial glycemia: which is the best target for improving outcomes? The Apollo and 4-T Trials
March 2010

Authors : Louis Monnier , Claude Colette

Affliation : University of Montpellier I, Institute of Clinical Research, 641 Avenue du Doyen Giraud, 34093 Montpellier Cedex 5, France ; ; louis.monnier@inserm.fr

DOI : 10.1517/14656566.0.0.344415

Published in : Expert Opin. Pharmacother.

Subject: Review

Keywords: basal and prandial insulin regimens , Type 2 diabetes

Abstract

Background: Two studies, the Apollo...

Please Login to read the full article.

RELATED CONTENT

NEWS Scrip News

Other Informa News

ANALYSIS Scrip Analysis

Other Informa Analysis

COMMENT Scrip Comment

Why you should worry about a patent's priority date

Other Informa Comment

Identity protection imperative in adverse incident reporting

FEATURES Scrip Features

Other Informa Features

SCIENCE

EVENTS

Congress on G Protein-Coupled Receptors in Drug Discovery

Today

Berlin, Germany

Drug Discovery Targets and Tools

Today

Berlin, Germany

Conference on Intellectual Property in the Pharmaceutical Industry

22 March 2010

London, UK

JOB OF THE WEEK Promote your vacancy here

DIRECTORY Scrip Directory 2009

This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36

Home

Therapy Sector

Generics

Business

Policy & Regulation

Research & Development

International

Terms & Conditions

Scrip Clinical Research

Animal Pharm